Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Significant is the Anticipated Growth Rate of the Salivary Gland Infection Market from 2025 to 2034?

The market for salivary gland infection has experienced robust growth in the recent past. The market value is predicted to increase from $4.12 billion in 2024 to $4.46 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.4%. The growth witnessed during the historical period is due to a surge in oral health problems, raised awareness about salivary disorders, an increase in bacterial and viral infections, the expansion of healthcare infrastructure, a growing geriatric population, and the rising preference for minimally invasive treatments.

The market for salivary gland infection treatment is projected to experience robust expansion in the coming years, with a growth estimation to reach $6.09 billion by 2029, boasting a CAGR of 8.1%. Numerous factors contribute to this prediction, including an increased public consciousness about oral health, prioritization of minimally invasive procedures, escalating rates of chronic conditions, enhancements in health care facilities, and broadening of avenues for patients to access specific care. Key trends forecasted for this period encompass embracing minimally invasive practices, progression in sialendoscopy techniques, avant-garde imaging technologies, development of biocompatible stents, application of robotic-assisted surgeries, preference for targeted antimicrobial treatments, and reliance on AI-driven diagnostic equipment.

What Factors Are Propelling the Growth of the Salivary Gland Infection Market from 2025 to 2034?

The escalation of issues pertaining to oral health is predicted to fuel the expansion of the market for salivary gland infections. Such oral health concerns encompass tooth decay, gum diseases and miscellaneous ailments concerning the mouth. The prevalence of oral health issues is propelled by ineffective oral cleanliness, poor dietary practices, and insufficiency in access to dental healthcare. The aggravation of oral health issues heightens the threat of salivary gland infections through the engendering of bacterial growth and obstructions in the salivary canals. For example, in May 2024, the National Health Service (NHS), a government agency based in the UK, reported that for the period of 2022-23, 32.5 million dental treatment sessions were administered, marking a 23.2% surge when juxtaposed with the prior year. Thus, the escalation of oral health problems substantiates the expansion of the market for salivary gland infections.

Explore Comprehensive Insights Into The Global Salivary Gland Infection Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21281&type=smp

Who Are the Dominant Players Pushing the Boundaries of the Salivary Gland Infection Market?

Major companies operating in the salivary gland infection market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly and Company, Gilead Sciences, Inc., Amgen Inc., FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Astellas Pharma Inc., Sandoz International GmbH, Vertex Pharmaceuticals Incorporated, Incyte Corporation., Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Mylan N.V., Zydus Cadila Healthcare Ltd.

How Are Market Trends Revolutionizing the Salivary Gland Infection Industry in Recent Times?

Leading corporations in the salivary gland infections market are focusing on technological upgrades, particularly in regards to minimally invasive procedures. This focus aims to boost treatment results, hasten patient healing, and optimize general healthcare performance. Minimally invasive procedures, which involve minor incisions and specific equipment, result in reduced tissue damage and expedite recovery. For example, Amrita Hospital, a healthcare establishment in India, introduced the Amrita Centre for minimally invasive salivary gland surgery in March 2024. This heralded a revolutionary treatment for dry mouth disorders using sialendoscopy, minimizing surgical needs and conserving gland function. The inauguration was marked with a two-day seminar featuring expert demonstrations.

Secure Your Global Salivary Gland Infection Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/salivary-gland-infection-global-market-report

How Are the Key Segments of the Salivary Gland Infection Market Driving Opportunities and Innovations?

The salivary gland infection market covered in this report is segmented –

1) By Diagnosis: Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses

2) By Treatment: Medications, Surgery, Aspiration, Home Care, Other Treatments

3) By End User: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User

Subsegments:

1) By Plain Radiography: X-ray Of Salivary Glands, Sialography With X-ray

2) By Sialography: Conventional Sialography, Digital Subtraction Sialography (DSS)

3) By Computed Tomography (CT): Non-contrast CT, Contrast-enhanced CT

4) By Magnetic Resonance Imaging (MRI): MRI without contrast, MRI With contrast (Dynamic MRI)

5) By Radionuclide Scintigraphy: Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography)

6) By High-resolution Ultrasonography: Standard Ultrasonography, Doppler Ultrasonography

7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test

Which Geographic Areas Are Influencing the Growth of the Salivary Gland Infection Market?

North America was the largest region in the salivary gland infection market in 2024. The regions covered in the salivary gland infection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Core Features That Define the Salivary Gland Infection Market?

Salivary gland infections are bacterial or viral infections that affect the salivary glands, leading to symptoms such as swelling, pain, and dry mouth. These infections occur in major glands such as the parotid, submandibular, and sublingual glands. They result from blockage, dehydration, or infections such as mumps.

Browse Through More Similar Reports By The Business Research Company:

Enzyme Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/enzyme-replacement-therapy-global-market-report

Global Diagnostic Enzyme Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-enzymes-global-market-report

Specialty Enzymes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/specialty-enzyme-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: